Protecting patients from infections, antibiotic resistance, and other adverse events
Official title: RFA-CK20-004: Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
Funded at University of Maryland Baltimore · NIH-11549943 · Data updated 2026-11-12
A national effort aims to prevent infections and antibiotic resistance in patients by linking hospitals, clinics, and labs to share best practices and rapid responses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | June 1, 2021 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $590,489 |
| NIH project number | 6U54CK000615-05M002 |
| Project ID | NIH-11549943 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients in healthcare settings (e.g., hospitals, clinics) at risk for infections or antibiotic-resistant conditions.
✕Less likely to help
Patients not exposed to hospital or clinical care pathways involved in this prevention program may not benefit directly.
What this research studies
This initiative focuses on preventing infections and reducing antibiotic resistance in real-world healthcare settings. It involves coordinating research across centers to identify risk factors, implement proven prevention strategies, and monitor adverse events that affect patients. The approach uses collaborative networks, data sharing, and targeted interventions to improve patient safety and outcomes. If successful, it could lead to safer care pathways and fewer infections for people receiving medical services.
Why it matters
Potential benefit: It could reduce infections and adverse events for patients, leading to safer hospital visits and better treatment outcomes.
How similar studies have gone: Previous prevention programs have shown reductions in hospital-associated infections when implemented with coordinated, cross-institutional strategies.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Harris, Anthony D — University of Maryland Baltimore
- Study coordinator: Harris, Anthony D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.